The Cutting Edge of Medical Technology Content, Community & Collaboration
Desktop Gene-Testing ... New Device Rapidly Analyzes Blood for Genetic Variations
Colleagues,
As reported in MIT Tech Review ... A desktop instrument recently approved by the U.S. Food and Drug Administration might finally bring pharmacogenomic testing--the use of a patient's genetic information for drug prescription decisions--to the mainstream.
Credit: Nanosphere
The device, made by Nanosphere, a startup based in Northbrook, Illinois, can, in a matter of hours, detect genetic variations in blood that modulate the effectiveness of some drugs. Dubbed Verigene, the technology employs a combination of microfluidics and nanotechnology, housed in a single plastic cartridge, to pull DNA from a blood sample and then screen it for the relevant sequences....
... "We believe the benefit of our system is that this simple cartridge format could be run in any hospital, even a doctor's office," says William Moffitt, chief executive at Nanosphere. "We're moving complex testing to the point of patient care." Moffitt says Verigene is the first nanotechnology-based microfluidics product capable of analyzing DNA directly from a blood sample...
Read on at: http://www.technologyreview.com/biomedicine/24042/?nlid=2569
As reported in MIT Tech Review ... A desktop instrument recently approved by the U.S. Food and Drug Administration might finally bring pharmacogenomic testing--the use of a patient's genetic information for drug prescription decisions--to the mainstream.
Credit: Nanosphere
The device, made by Nanosphere, a startup based in Northbrook, Illinois, can, in a matter of hours, detect genetic variations in blood that modulate the effectiveness of some drugs. Dubbed Verigene, the technology employs a combination of microfluidics and nanotechnology, housed in a single plastic cartridge, to pull DNA from a blood sample and then screen it for the relevant sequences....
... "We believe the benefit of our system is that this simple cartridge format could be run in any hospital, even a doctor's office," says William Moffitt, chief executive at Nanosphere. "We're moving complex testing to the point of patient care." Moffitt says Verigene is the first nanotechnology-based microfluidics product capable of analyzing DNA directly from a blood sample...
Read on at: http://www.technologyreview.com/biomedicine/24042/?nlid=2569
Views: 7
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
